FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3637811000001103: Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22301301000001114 Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38253101000001119 Bendroflumethiazide 2.5mg / Potassium chloride 630mg (potassium 8.4mmol) modified-release tablets 100 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet Is pack of Bendrofluazide+potassium 2.5mg/8.4Mmol m/r tablet false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet Has active ingredient Potassium chloride false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet Has active ingredient Potassium false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet Has active ingredient Bendroflumethiazide false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet Has active ingredient Bendrofluazide - chemical false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet Has VMP Bendrofluazide+potassium 2.5mg/8.4Mmol m/r tablet false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet Has specific active ingredient Potassium chloride true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet Has specific active ingredient Bendroflumethiazide true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet Has VMP Bendroflumethiazide 2.5mg / Potassium chloride 630mg (potassium 8.4mmol) modified-release tablets false Inferred relationship Existential restriction modifier
Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet Has VMP Bendroflumethiazide 2.5mg / Potassium chloride 630mg (potassium 8.4mmol) modified-release tablets true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Neo-Naclex-K modified-release tablets (Goldshield Healthcare Ltd) 100 tablet Is a True Bendroflumethiazide 2.5mg / Potassium 8.4mmol modified-release tablets 100 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start